Factor VII Arg/Gln353 polymorphism determines factor VII coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM study
- 1 January 1996
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 119 (1) , 119-127
- https://doi.org/10.1016/0021-9150(95)05638-6
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Activation of coagulation factor VII during alimentary lipemia.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Lipolysis of triglyceride-rich lipoproteins activates coagulant factor XII: A study in familial lipoprotein-lipase deficiencyAtherosclerosis, 1992
- Plasma factor VII is activated by postprandial triglyceridaemia, irrespective of dietary fat compositionAtherosclerosis, 1991
- The prothrombin activation peptide regulates synthesis of the vitamin K-dependent proteins in the rabbitThrombosis Research, 1990
- Association between coagulation factors VII and X with triglyceride rich lipoproteins.Journal of Clinical Pathology, 1988
- HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDYThe Lancet, 1986
- Association between dietary fat intake and plasma factor VII coagulant activity — A predictor of cardiovascular mortalityAtherosclerosis, 1986
- FURTHER EVIDENCE THAT ACTIVATED FACTOR VII IS RELATED TO PLASMA LIPIDSBritish Journal of Haematology, 1985
- Assay of factor VII activity by two techniques: evidence for increased conversion of VII to αVIIain hyperlipidaemia, with possible implications for ischaemic heart diseaseBritish Journal of Haematology, 1985
- HYPERTRIGLYCERIDAEMIA AND HYPERCOAGULABILITYThe Lancet, 1983